Intravesical-bacteriophages-for-treating-urinary-tract-infect_2020_The-Lance.pdf
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial
Lorenz Leitner MD
the abstract see Online for appendix 1 appendix 1 For the German translation of the abstract see Online for appendix 2 Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland (L Leitner MD, S McCallin PhD, M P Schneider MD, M D Liechti PhD, U Mehnert MD, W Sybesma PhD, Prof T M Kessler MD); Alexander Tsulukidze National Centre of Urology, Tbilisi, Georgia (A Ujmajuridze MD, Prof A Chkhotua MD, G Changashvili MD); Eliava Institute of Bacteriophage, Microbiology, and Virology, Tbilisi, Georgia (N Chanishvili PhD, M Goderdzishvili PhD, I Chkonia PhD, S Rigvava PhD); Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland (S McCallin); Medignition Research Consultants, Zürich, Switzerland (Prof L M Bachmann PhD); and Yoba for Life Foundation, Amsterdam, Netherlands (W Sybesma) Correspondence to: Prof Thomas M Kessler, Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich 8008, Switzerland tkessler@gmx.ch 
